Company: RGBP
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001641172-25-022884
Chunk: 11

Company: Regen BioPharma Inc
Filing Date: 2025-08-11
Form: 10-Q
Item: Part I, Item 1
Chunk 11
---
 shall receive,
out of assets legally available for distribution to the Company’s stockholders, a ratable share in the assets of the Corporation.

Preferred
Stock, $ 0.0001 800,000,000 600,000 34 739,000,000 10,123,771 60,000,000 29,338 20,000 15,007

The
abovementioned shares authorized pursuant to the Company’s certificate of incorporation may be issued from time to time without
prior approval of the shareholders. The Board of Directors of the Company shall have the full authority permitted by law to establish
one or more series and the number of shares constituting each such series and to fix by resolution full or limited, multiple or fractional,
or no voting rights, and such designations, preferences, qualifications, restrictions, options, conversion rights and other special or
relative rights of any series of the Stock that may be desired.

  Series              

On
September 15, 2014 the Company filed a CERTIFICATE OF DESIGNATION (“ Certificate of Designations”) with the Nevada Secretary
of State setting forth the preferences rights and limitations of a newly authorized series of preferred stock designated and known as
“ Series AA Preferred Stock” (hereinafter referred to as “ Series AA Preferred Stock”).

The
Board of Directors of the Company have authorized 600,000 0.0001

  Series             

On
January 15, 2015 the Company filed a CERTIFICATE OF DESIGNATION (“ Certificate of Designations”) with the Nevada Secretary
of State setting forth the preferences rights and limitations of a newly authorized series of preferred stock designated and known as
“ Series A Preferred Stock” (hereinafter referred to as “ Series A Preferred Stock”).

The
Board of Directors of the Company have authorized 739,000,000 0.0001

Holders
of the Series A Preferred Stock will be entitled to receive, when, as and if declared by the board of directors of the Company (the “ Board”)
out of funds legally available therefore, non-cumulative cash dividends of $ 0.01

Upon
any liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary (collectively, a “ Liquidation”),
before any distribution or payment shall be made to any of the holders of Common Stock or any other series of preferred stock, the holders
of Series A Preferred Stock shall be entitled to receive out of the assets of